Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes

Diabetes

Volumn 51, Issue 8, 2002, Pages 2474-2480

  Lohmann, T ^a,b   Laue, S ^a   Nietzschmann, U ^a   Kapellen, T M ^a   Lehmann, I ^a   Schroeder, S ^a   Paschke, R ^a   Kiess, W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MALE; MONONUCLEAR CELL; PANCREATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0036326436     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.8.2474     Document Type: Article

References (39)

1. Type I diabetes: A chronic autoimmune disease
2. Insulin-dependent diabetes mellitus
3. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice
4. Diabetes results from a late change in the autoimmune response of NOD mice
5. The Diabetes Prevention Trial-Type 1 Diabetes (DPT-1): Implementation of screening and staging of relatives
6. Properties of the novel proinflammatory supergene "intercrine" cytokine family
7. Chemokines: Chemotactic cytokines that mediate inflammation
8. Chemokines: A new classification system and their role in immunity
9. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes
10. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes
11. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
12. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
13. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
14. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells
15. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Grave's disease
16. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
17. Extreme Th1 bias of invariant Vα24JαQT cells in type I diabetes
18. β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice
19. Immune markers for monitoring the progression of autoimmune disease
20. The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus
21. Multiple immuno-regulatory defects in type-1 diabetes
22. + regulatory T cells
23. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential
24. Elevated serum IP-10 levels observed in type 1 diabetes
25. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalitis
26. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein
27. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produce monocyte-rich insulitis without diabetes
28. H2 polarization by the chemokine monocyte chemoattractant protein-1
29. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection
30. Inhibition of CCR5 expression by IL-12 through induction of β-chemokines in human T lymphocytes
31. Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membraneous ICAM-1
32. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
33. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
34. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis
35. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis
36. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis
37. TNF-α-induced secretion of C-C chemokines modlates C-C chemokine receptor 5 expression on peripheral blood lymphocytes
38. Th1-like dominance in high-risk first-degree relatives of type 1 diabetic patients
39. "Lady-like": Is there a latent autoimmune diabetes in the young?